Discovery and Development of Novel GSK‐3β Inhibitor for the management of Alzheimer's disease

This design strategy could be used for the lead optimization of GSK-3β Inhibitors and focusing attention on the exciting therapy could thus reap considerable clinical and economic rewards.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_102577
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery and Development of Novel GSK‐3β Inhibitor for the management of Alzheimer's disease

Manjinder Singh, Samanta Gambhir
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Discovery and Development of Novel GSK‐3β Inhibitor for the management of Alzheimer's disease

Manjinder Singh, Samanta Gambhir
article en

Abstract

This design strategy could be used for the lead optimization of GSK-3β Inhibitors and focusing attention on the exciting therapy could thus reap considerable clinical and economic rewards.

Alzheimer s & DementiaVol. 21(S5)
Chitkara University (IN)
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Discovery and Development of Novel GSK‐3β Inhibitor for the management of Alzheimer's disease — Manjinder Singh, Samanta Gambhir · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS